SunforestXTherapeutics
Therapeutic precision platform

Discovery Engine

An integrated workflow from data to mechanism to human‑relevant validation, designed for precision rare disease discovery.

Integrated discovery workflow

1

Data integration

Multi‑omics, clinical, and biomedical data

→
2

Mechanism prioritization

AI/ML‑informed target identification

→
3

Therapeutic design

Tailored small‑molecule strategies

→
4

Human‑relevant validation

Organ‑on‑a‑chip & functional assays

→
5

Program advancement

Partnership‑driven translation

Scientific workflow visualization showing data integration and analysis pipelines

Computational workflows integrate diverse data types for mechanism‑focused discovery.

Core platform capabilities

AI/ML-enabled discovery

Supports target prioritisation, signal extraction, and decision support across complex rare disease biology.

Multi-omics integration

Connects genomic, transcriptomic, and other biological layers to mechanism-level insight.

Tailored targeting

Designed against pathogenic transcription factors, enzymes, and DNA/RNA-related disease mechanisms.

Organ-on-a-chip validation

Human-relevant systems improve translational confidence earlier in development.

International CRO execution

Extends specialised assay and development capability beyond the in-house core.

Replicable architecture

Built to support repeatable discovery across multiple rare congenital disease programs.